**Core Concept**
Methoctramine is a medication that acts as an antagonist at muscarinic acetylcholine receptors, specifically at the M1 subtype. This action is used to treat conditions associated with excessive parasympathetic tone, such as bradycardia and excessive salivation.

**Why the Correct Answer is Right**
Methoctramine competes with acetylcholine for binding to muscarinic receptors, thereby reducing the effects of acetylcholine and decreasing parasympathetic activity. This action is mediated through the blockade of M1 receptors, which are involved in the regulation of smooth muscle contraction and glandular secretion. By blocking these receptors, methoctramine can help to alleviate symptoms associated with excessive parasympathetic activity.

**Why Each Wrong Option is Incorrect**
**Option A:** Methoctramine is not a beta-blocker, as it does not act on adrenergic receptors to decrease heart rate or blood pressure.
**Option B:** Methoctramine is not an anticholinesterase, as it does not increase acetylcholine levels by inhibiting its breakdown.
**Option C:** Methoctramine is not an antihistamine, as it does not act on histamine receptors to reduce allergic responses.

**Clinical Pearl / High-Yield Fact**
Methoctramine is particularly useful in the treatment of bradycardia associated with vagal stimulation, such as in cases of vasovagal syncope or during surgical procedures. Its ability to selectively block muscarinic receptors makes it a valuable adjunct in the management of these conditions.

**Correct Answer:** D.